Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Solid dose imprinting

This article was originally published in The Tan Sheet

Executive Summary

Nonprescription Drug Manufacturers Association notes in a Sept. 16 release that about 95% of OTCs sold in solid dose form are already imprinted with identification codes under a voluntary program initiated by the industry in 1989. On Sept. 13, FDA issued solid dosage form imprinting final regs ("The Tan Sheet" Sept. 13, p. 17), which NDMA said are "virtually identical" to the industry program. In the final rule, FDA estimated that 70% of OTC drugs are imprinted.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS081929

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel